Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1989 4
1990 2
1991 6
1992 6
1993 8
1994 1
1995 2
1996 3
1997 5
1998 1
2000 3
2004 1
2009 1
2010 4
2011 2
2012 4
2013 1
2014 1
2015 1
2016 3
2017 4
2018 3
2019 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Nizatidine anaphylaxis.
Mira-Perceval JL, Ortiz JL, Sarrió F, Miralles JC, Hernández J, Negro-Alvarez JM, López-Sánchez JD, García-Sellés FJ, Pagán JA. Mira-Perceval JL, et al. Among authors: ortiz jl. J Allergy Clin Immunol. 1996 Mar;97(3):855-6. doi: 10.1016/s0091-6749(96)80165-5. J Allergy Clin Immunol. 1996. PMID: 8613644 No abstract available.
Leukotrienes and their antagonists in allergic disorders.
Negro JM, Miralles JC, Ortiz JL, Funes E, García A. Negro JM, et al. Among authors: ortiz jl. Allergol Immunopathol (Madr). 1997 Mar-Apr;25(2):104-12. Allergol Immunopathol (Madr). 1997. PMID: 9150842 Review.
Biosynthesis inhibitors for leukotrienes in bronchial asthma.
Negro JM, Miralles JC, Ortiz JL, Funes E, García A. Negro JM, et al. Among authors: ortiz jl. Allergol Immunopathol (Madr). 1997 Jul-Aug;25(4):209-16. Allergol Immunopathol (Madr). 1997. PMID: 9269512 Review.
A dense ring of the trans-Neptunian object Quaoar outside its Roche limit.
Morgado BE, Sicardy B, Braga-Ribas F, Ortiz JL, Salo H, Vachier F, Desmars J, Pereira CL, Santos-Sanz P, Sfair R, de Santana T, Assafin M, Vieira-Martins R, Gomes-Júnior AR, Margoti G, Dhillon VS, Fernández-Valenzuela E, Broughton J, Bradshaw J, Langersek R, Benedetti-Rossi G, Souami D, Holler BJ, Kretlow M, Boufleur RC, Camargo JIB, Duffard R, Beisker W, Morales N, Lecacheux J, Rommel FL, Herald D, Benz W, Jehin E, Jankowsky F, Marsh TR, Littlefair SP, Bruno G, Pagano I, Brandeker A, Collier-Cameron A, Florén HG, Hara N, Olofsson G, Wilson TG, Benkhaldoun Z, Busuttil R, Burdanov A, Ferrais M, Gault D, Gillon M, Hanna W, Kerr S, Kolb U, Nosworthy P, Sebastian D, Snodgrass C, Teng JP, de Wit J. Morgado BE, et al. Among authors: ortiz jl. Nature. 2023 Feb;614(7947):239-243. doi: 10.1038/s41586-022-05629-6. Epub 2023 Feb 8. Nature. 2023. PMID: 36755175 Free article.
Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
Ortiz-Seller A, Martorell P, Barranco H, Pascual-Camps I, Morcillo E, Ortiz JL. Ortiz-Seller A, et al. Among authors: ortiz jl. Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008-0. doi: 10.1016/j.survophthal.2024.02.005. Online ahead of print. Surv Ophthalmol. 2024. PMID: 38432359 Free article. Review.
73 results